51 related articles for article (PubMed ID: 18628319)
21. [Comparison between PET(-FDG) and computed tomography in the staging of lung cancer. Consequences for operability in 94 patients].
Prévost A; Papathanassiou D; Jovenin N; Menéroux B; Cuif-Job A; Bruna-Muraille C; Domange-Testard A; Liehn JC
Rev Pneumol Clin; 2009 Dec; 65(6):341-9. PubMed ID: 19995654
[TBL] [Abstract][Full Text] [Related]
22. The clinicopathological features associated with skip N2 metastases in patients with clinical stage IA non-small-cell lung cancer.
Gorai A; Sakao Y; Kuroda H; Uehara H; Mun M; Ishikawa Y; Nakagawa K; Masuda M; Okumura S
Eur J Cardiothorac Surg; 2015 Apr; 47(4):653-8. PubMed ID: 24957260
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological features of small-sized non-small cell lung cancer with mediastinal lymph node metastasis.
Fukui T; Katayama T; Ito S; Abe T; Hatooka S; Mitsudomi T
Lung Cancer; 2009 Dec; 66(3):309-13. PubMed ID: 19344976
[TBL] [Abstract][Full Text] [Related]
24. Probability of mediastinal involvement in non-small-cell lung cancer: a statistical definition of the clinical target volume for 3-dimensional conformal radiotherapy?
Giraud P; De Rycke Y; Lavole A; Milleron B; Cosset JM; Rosenzweig KE
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):127-35. PubMed ID: 16226394
[TBL] [Abstract][Full Text] [Related]
25. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
26. Value of dual time point F-18 FDG-PET/CT imaging for the evaluation of prognosis and risk factors for recurrence in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy.
Satoh Y; Nambu A; Onishi H; Sawada E; Tominaga L; Kuriyama K; Komiyama T; Marino K; Aoki S; Araya M; Saito R; Maehata Y; Oguri M; Araki T
Eur J Radiol; 2012 Nov; 81(11):3530-4. PubMed ID: 22178287
[TBL] [Abstract][Full Text] [Related]
27. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.
Hsu CP; Hsia JY; Chang GC; Chuang CY; Shai SE; Yang SS; Lee MC; Kwan PC
J Thorac Cardiovasc Surg; 2009 Aug; 138(2):426-33. PubMed ID: 19619791
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of the number of removed lymph nodes at lobectomy in patients with positron emission tomography-computed tomography-negative N2 non-small cell lung cancer.
Tsai YM; Huang TW; Hsu HH; Cheng CY; Lin YC; Cheng YL; Chang H; Lee SC
Onkologie; 2013; 36(9):492-6. PubMed ID: 24051925
[TBL] [Abstract][Full Text] [Related]
29. Integrated positron emission tomography and computed tomography in preoperative lymph node staging of non-small cell lung cancer.
Xu N; Wang M; Zhu Z; Zhang Y; Jiao Y; Fang W
Chin Med J (Engl); 2014; 127(4):607-13. PubMed ID: 24534208
[TBL] [Abstract][Full Text] [Related]
30. [The use of CT in the treatment of lung cancer with radiation therapy].
Fuwa N; Morita K; Okumura E; Horikawa Y; Uchiyama Y; Suyama M
Gan No Rinsho; 1987 Apr; 33(4):369-73. PubMed ID: 3033347
[TBL] [Abstract][Full Text] [Related]
31. Elective nodal irradiation for locally advanced non-small-cell lung cancer: it's called cancer for a reason.
Kelsey CR; Marks LB; Glatstein E
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1291-2. PubMed ID: 19306745
[No Abstract] [Full Text] [Related]
32. [Quantitative studies on expression of peripheral blood CD44 and CD54 in non-small cell lung carcinoma].
Chen Q; Zhou J; Wu Y
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Oct; 24(10):605-7. PubMed ID: 11770423
[TBL] [Abstract][Full Text] [Related]
33. Is computed tomography simulation associated with improved survival, or is this finding a result of confounding variables?
Koshy M
J Clin Oncol; 2011 Sep; 29(26):3587; author reply 3587-8. PubMed ID: 21825261
[No Abstract] [Full Text] [Related]
34. Identifying patients with peripheral-type early non-small cell lung cancer (T1N0M0) for whom irradiation of the primary focus alone could lead to successful treatment.
Fuwa N; Daimon T; Mitsudomi T; Yatabe Y; Kodaira T; Tachibana H; Nakamura T; Kato T; Sato Y
Br J Radiol; 2008 Oct; 81(970):815-20. PubMed ID: 18628319
[TBL] [Abstract][Full Text] [Related]
35. Factors involved in lymph node metastasis in clinical stage I non-small cell lung cancer--from studies of 604 surgical cases.
Fuwa N; Mitsudomi T; Daimon T; Yatabe Y; Shinoda M; Hatooka S; Mori S; Fukui T; Inaba Y
Lung Cancer; 2007 Sep; 57(3):311-6. PubMed ID: 17509726
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement.
Inoue M; Minami M; Shiono H; Sawabata N; Ideguchi K; Okumura M
J Thorac Cardiovasc Surg; 2006 May; 131(5):988-93. PubMed ID: 16678580
[TBL] [Abstract][Full Text] [Related]
37. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
[TBL] [Abstract][Full Text] [Related]
38. Lymph node involvement in T1 non-small-cell lung cancer: could glucose uptake and maximal diameter be predictive criteria?
Casiraghi M; Travaini LL; Maisonneuve P; Tessitore A; Brambilla D; Agoglia BG; Guarize J; Spaggiari L
Eur J Cardiothorac Surg; 2011 Apr; 39(4):e38-43. PubMed ID: 21242094
[TBL] [Abstract][Full Text] [Related]
39. Resected non-small cell lung cancer: need for adjuvant lymph node treatment? From hope to reality.
Arriagada R; Le Péchoux C; Pignon JP
Lung Cancer; 2003 Dec; 42 Suppl 1():S57-64. PubMed ID: 14611916
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
